The present disclosure is directed to oral tablet of ribociclib including itssalt(s). One embodiment of the present disclosureis directed to tablet of ribociclib with high drug load with an immediaterelease profile. One embodiment of the present disclosureis directed to coated tablet of ribociclib. Another embodiment of the presentdisclosure is directed to coated tablet of ribociclibwhere the coating is an advanced moisture barrier coating (e.g., Opadry®amb II coating where the coating is PVA based).
